
Timothy Cripe
Preview

Speaker Affiliation
Timothy Cripe, M.D., Ph.D., Chief, Division of Hematology and Oncology at Nationwide Children’s Hospital, A Gordon Teter Endowed Chair in Pediatric Cancer at Nationwide Children’s Hospital, Professor of Pediatrics at The Ohio State University
Presentation: Immuno-Gene Therapy for Cancer: A New Frontier
Biography
Dr. Cripe is the Chief of the Division of Pediatric Hematology/Oncology/Blood and Marrow Transplant and the Gordon Teter Endowed Chair in Pediatric Cancer at Nationwide Children’s Hospital. He is also a principal investigator in the Center for Childhood Cancer Research at the Abigail Wexner Research Institute at Nationwide Children’s Hospital. He is a tenured Professor of Pediatrics at The Ohio State University Wexner College of Medicine and a member of the Translational Therapeutics Program and the Pelotonia Institute for Immuno-Oncology at the OSU Comprehensive Cancer Center. His research is focused on the laboratory-based development and early phase clinical testing of cellular, viral and gene therapies for pediatric cancers and has been supported by numerous extramural grants including multiple R-, U- and P-level NIH grants. He has published over 170 peer-reviewed manuscripts and delivered over 220 invited lectures. He is the PI of a T32 training grant in pediatric cancer. He is the former chair of the FDA’s Cellular, Tissue and Gene Therapy Advisory Committee. He serves as the Editor-in-Chief of the flagship cancer journal of the American Society of Cell and Gene Therapy, Molecular Therapy Oncology. He is the founder of the educational podcast series “This Week in Pediatric Oncology,” and has published 112 episodes. He is co-founder and board member of Vironexis Biotherapeutics, Inc., a clinical stage cancer gene therapy company.